CDH1 and non-small cell lung carcinoma: By contrast, 35.1%, 62.3% and 54.5% of NSCLC specimens with low miR-128-3p expression expressed low levels of E-cadherin, Vimentin and CD34, respectively (Fig. 8a,b), suggesting tight clinical correlations among miR-128-3p levels, activated β-catenin and TGF-β signalling, and pro-EMT/pro-metastatic protein expression levels.